Revenue
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Axogen, Inc. (AXGN)
Price$42.16Cached quote
Net income
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $225.2M | $187.3M | $159.0M | $138.6M | $127.4M | $112.3M | $106.7M | $83.9M | $60.4M | $41.1M | $27.3M | $16.8M | $10.9M | $7.7M | $4.8M | $3.0M |
| Gross profit | $167.4M | $142.0M | $121.9M | $108.8M | $104.4M | $90.7M | $89.4M | $71.0M | $51.1M | $34.6M | $22.5M | $13.4M | $8.5M | $5.7M | $2.4M | $1.6M |
| Gross margin | 74.31% | 75.79% | 76.64% | 78.51% | 81.99% | 80.78% | 83.74% | 84.60% | 84.59% | 84.27% | 82.26% | 79.53% | 77.71% | 74.49% | 49.96% | 54.10% |
| Research & development | $32.9M | $27.8M | $27.3M | $25.6M | $24.2M | $17.8M | $17.5M | $11.8M | $6.7M | $4.2M | $3.2M | $3.0M | $2.1M | $1.4M | $697,355 | $436,008 |
| Operating expenses | $175.2M | $145.3M | $143.3M | $138.5M | $129.8M | $113.9M | $120.8M | $91.5M | $59.1M | $42.8M | $31.7M | $23.2M | $18.1M | $13.5M | $9.4M | $6.1M |
| Operating income | −$7.8M | −$3.3M | −$21.5M | −$29.7M | −$25.4M | −$23.2M | −$31.4M | −$20.5M | −$8.0M | −$8.1M | −$9.3M | −$9.8M | −$9.6M | −$7.8M | −$7.0M | −$4.5M |
| Operating margin | −3.49% | −1.75% | −13.50% | −21.44% | −19.96% | −20.64% | −29.43% | −24.42% | −13.16% | −19.78% | −33.91% | −58.28% | −87.62% | −101.43% | −143.70% | −149.16% |
| EBITDA | −$1.2M | $3.2M | −$17.2M | −$26.9M | −$22.7M | −$21.7M | −$30.4M | −$19.6M | −$7.4M | −$7.7M | −$9.0M | −$9.6M | −$9.5M | −$7.6M | −$6.7M | −$4.1M |
| EBITDA margin | −0.53% | 1.70% | −10.84% | −19.40% | −17.80% | −19.28% | −28.44% | −23.41% | −12.22% | −18.71% | −32.99% | −57.36% | −86.90% | −98.99% | −138.06% | −137.41% |
| Net income | −$15.7M | −$10.0M | −$21.7M | −$28.9M | −$27.0M | −$23.8M | −$29.1M | −$22.4M | −$10.4M | −$14.4M | −$13.4M | −$17.7M | −$14.6M | −$9.4M | −$9.2M | −$5.4M |
| Net profit margin | −6.97% | −5.32% | −13.66% | −20.89% | −21.19% | −21.18% | −27.30% | −26.68% | −17.29% | −35.06% | −48.87% | −105.31% | −132.97% | −122.44% | −190.11% | −180.50% |
| Basic EPSper basic share | -$0.34 | -$0.23 | -$0.51 | -$0.69 | -$0.65 | -$0.60 | -$0.74 | -$0.60 | -$0.31 | -$0.47 | -$0.51 | -$0.99 | -$1.08 | -$0.85 | -$2.77 | -$8.35 |
| Diluted EPSper diluted share | -$0.34 | -$0.23 | -$0.51 | -$0.69 | -$0.65 | -$0.60 | -$0.74 | -$0.60 | -$0.31 | -$0.47 | -$0.51 | -$0.99 | -$1.08 | -$0.85 | -$2.77 | -$8.35 |
Owners
Reported shareholders
8.24%of listed shares
BlackRock, Inc.4.42M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | 8.24%4.42M shares |
First Light Asset Management, LLC | 5.12%2.75M shares |
MORGAN STANLEY | 5.12%2.75M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 4.21%2.26M shares |
Assenagon Asset Management S.A. | 3.89%2.09M shares |
Polar Capital Holdings Plc | 2.80%1.5M shares |
Artemis Investment Management LLP | 2.60%1.4M shares |
WELLINGTON MANAGEMENT GROUP LLP | 2.59%1.39M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.56%1.38M shares |
CITADEL ADVISORS LLC | 2.54%1.36M shares |
WASATCH ADVISORS LP | 2.42%1.3M shares |
GOLDMAN SACHS GROUP INC | 2.35%1.26M shares |
STATE STREET CORP | 2.32%1.25M shares |
FMR LLC | 2.28%1.22M shares |
Hood River Capital Management LLC | 1.99%1.07M shares |
PRICE T ROWE ASSOCIATES INC /MD/ | 1.90%1.02M shares |
RTW INVESTMENTS, LP | 1.89%1.01M shares |
NEXT CENTURY GROWTH INVESTORS LLC | 1.63%872.55K shares |
UBS Group AG | 1.56%836.21K shares |
ARMISTICE CAPITAL, LLC | 1.44%775K shares |
Percentages use 53.66M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 8, 2026Form 4 | Wendell Amy McBrideDirector | SellCommon Stock | 1.6K | $42.60 | $70.2K | 93.8K |
| May 7, 2026Form 4 | JOHNSON JOHNDirector | SellCommon Stock | 11.1K | $43.26 | $478.0K | 0 |
| May 7, 2026Form 4 | Weiler Kathy JohnsonDirector | SellCommon Stock | 16.3K | $44.09 | $720.6K | 0 |
| May 7, 2026Form 4 | Kemp JensChief Marketing Officer | SellCommon Stock | 4.0K | $43.44 | $173.8K | 72.5K |
| May 7, 2026Form 4 | Hartley Lindsey MarieCFO | SellCommon Stock | 573 | $43.67 | $25.0K | 65.1K |
Community posts
Axogen pairs a $200 million BioCircuit acquisition with a share offering
Axogen ($AXGN) agreed to acquire BioCircuit Technologies for $200 million in cash, adding the NerveTape platform for sutureless peripheral-nerve repair. The buyer expects the transaction to support revenue growth and improve adjusted EBITDA ...
